Promising Cholesterol Drug Falls Flat, Leaving Patients and Taxpayers High and Dry
The experimental treatment that was hailed as a breakthrough failed to prevent heart attacks or strokes, confirming skeptics' doubts about elite health promises.
The experimental drug that was expected to lower a common risk factor for heart attacks failed to save patients' lives, as doctors had expected.
In a clinical trial, the same drug showed no measurable impact on heart attack or stroke.
"The ‘slam dunk’ that wasn’t: Promising cholesterol drug fails to prevent heart attacks or stroke"
Loading comments…
Original reporting
NPR
A promising new medicine against heart disease fails unexpectedly
Doctors expected an experimental drug that lowers a common risk factor for heart attacks would save patients' lives. The medicine made no difference.
Read the original →NBC News
The ‘slam dunk’ that wasn’t: Promising cholesterol drug fails to prevent heart attacks or stroke
An experimental drug that held great promise in driving down a dangerous form of cholesterol didn’t show any measurable impact on heart attack or stroke in a clinical trial.
Read the original →
Facts this version was allowed to use
- An experimental drug that lowers a common risk factor for heart attacks failed to save patients' lives, as doctors had expected.
- In a clinical trial, an experimental drug that lowers a dangerous form of cholesterol showed no measurable impact on heart attack or stroke.
- The ‘slam dunk’ that wasn’t: Promising cholesterol drug fails to prevent heart attacks or stroke (NBC News headline)
Reader comments
Written by readers: not by Lens, its AI or the outlets it credits. Comments are screened before they show. Community rules
No comments yet. Be the first.